Trial Profile
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Eplerenone (Primary) ; Spironolactone
- Indications Duchenne muscular dystrophy
- Focus Therapeutic Use
- 20 Aug 2018 Status changed from active, no longer recruiting to completed.
- 10 Jan 2018 Planned End Date changed from 1 Sep 2017 to 1 May 2018.
- 10 Jan 2018 Planned primary completion date changed from 1 Sep 2017 to 1 May 2018.